It also promotes neurofibrillary degeneration directly through hyperphosphorylation of tau and indirectly through phosphorylation of alternative splicing factor, therefore participating to neurodegeneration and neuronal loss appearing in AD (54–56). This evidence concerns the gene MAPT and Alzheimer disease.